INFLUENCE OF DOSAGE FORM ON PAPAVERINE BIOAVAILABILITY

被引：8
|
作者：
MEYER, MC [1 ]
GOLLAMUDI, R [1 ]
STRAUGHN, AB [1 ]
机构：
[1] UNIV TENNESSEE,CTR HLTH SCI,COLL PHARM,DEPT MED CHEM,MEMPHIS,TN 38163
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1979年 / 19卷 / 8-9期
关键词：
D O I：
10.1002/j.1552-4604.1979.tb02505.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：435 / 444
页数：10
相关论文
共 50 条
  • [1] ORAL DOSAGE FORM INFLUENCE ON PARACETAMOL BIOAVAILABILITY
    PARIER, JL
    PICARD, O
    BONHOMME, L
    FREDJ, G
    RINGARD, J
    GLUCK, C
    JOURNAL DE PHARMACIE DE BELGIQUE, 1988, 43 (04) : 287 - 291
  • [2] AMPICILLIN SYSTEMIC BIOAVAILABILITY - INFLUENCE OF DOSAGE FORM
    DUGAL, R
    BRODEUR, J
    CAILLE, G
    JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 14 (10): : 513 - 519
  • [3] BIOAVAILABILITY OF 3.519 CERM - INFLUENCE OF DOSAGE FORM ADDITIVES
    AIACHE, JM
    POGNAT, JF
    BOUDAL, P
    JOURNAL DE PHARMACIE DE BELGIQUE, 1980, 35 (02) : 85 - 97
  • [4] Influence of route of administration and dosage form in the pharmacokinetics and bioavailability of salbutamol
    Hernandez, RM
    Gascon, AR
    Calvo, MB
    Caramella, C
    Conte, U
    DominguezGil, A
    Pedraz, JL
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1997, 22 (02) : 145 - 150
  • [5] Influence of route of administration and dosage form in the pharmacokinetics and bioavailability of salbutamol
    R. M. Hernández
    A. R. Gascón
    M. B. Calvo
    C. Caramella
    U. Conte
    A. Domínguez-Gil
    J. L. Pedraz
    European Journal of Drug Metabolism and Pharmacokinetics, 1997, 22 : 145 - 150
  • [6] BIOAVAILABILITY STUDY OF GITOXIN IN A SOLID DOSAGE FORM
    HUPIN, C
    DESURAY, JM
    VERSLUYS, J
    LORENT, M
    DODION, L
    LESNE, M
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND BIOPHARMACY, 1979, 17 (05): : 197 - 204
  • [7] COMPARATIVE BIOAVAILABILITY OF PAPAVERINE HYDROCHLORIDE, PAPAVERINE HEXAMETAPHOSPHATE AND PAPAVERINE POLYMETAPHOSPHATE
    PATEL, TR
    SCHOENWALD, RD
    LACH, JL
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1981, 7 (03) : 329 - 345
  • [8] VARIABLE BIOAVAILABILITY OF PAPAVERINE
    BERG, G
    JONSSON, KA
    HAMMAR, M
    NORLANDER, B
    PHARMACOLOGY & TOXICOLOGY, 1988, 62 (05): : 308 - 310
  • [9] PHARMACOKINETICS AND BIOAVAILABILITY OF PAPAVERINE
    JUHRAN, W
    HAASE, W
    GOTZ, R
    FLEISSIG, W
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1975, 25 (05): : 771 - 773
  • [10] Enhanced efficacy and bioavailability of thymoquinone using nanoliposomal dosage form
    Mohammadabadi, M. R.
    Mozafari, M. R.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 47 : 445 - 453
12345